Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons
Matthew E. Gegg, Guglielmo Verona, Anthony H.V. Schapira
Human Molecular Genetics (2020) Vol. 29, Iss. 10, pp. 1716-1728
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 135
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Mylene Huebecker, Elizabeth B. Moloney, Aarnoud C. van der Spoel, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 134
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
Kai Zhang, Shiou Zhu, Jiamei Li, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3015-3034
Open Access | Times Cited: 93
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Inês Caldeira Brás, Tiago F. Outeiro
Cells (2021) Vol. 10, Iss. 2, pp. 375-375
Open Access | Times Cited: 92
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Patricia García‐Sanz, Johannes M. F. G. Aerts, Rosario Moratalla
Movement Disorders (2020) Vol. 36, Iss. 5, pp. 1070-1085
Open Access | Times Cited: 89
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Matthew E. Gegg, Elisa Menozzi, Anthony H.V. Schapira
Neurobiology of Disease (2022) Vol. 166, pp. 105663-105663
Open Access | Times Cited: 48
Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance–Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study
Ying Meng, Christopher B. Pople, Yuexi Huang, et al.
Movement Disorders (2022) Vol. 37, Iss. 10, pp. 2134-2139
Open Access | Times Cited: 40
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues
Elisa Menozzi, Marco Toffoli, Anthony H.V. Schapira
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108419-108419
Open Access | Times Cited: 24
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons
Helle Bogetofte, Brent J. Ryan, Pia Jensen, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112180-112180
Open Access | Times Cited: 21
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
Eddie Pradas, Marta Martínez‐Vicente
Cells (2023) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 20
The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art
Júlio César Claudino dos Santos, Gabriela Braga Cabrera Mano, André Rodrigues da Cunha Barreto Vianna, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6754-6770
Closed Access | Times Cited: 7
Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis
Gizem Önal, Gül Yalçın‐Çakmaklı, Cemile Elif Özçelik, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 6
GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
Young Eun Huh, Tatiana Usnich, Clemens R. Scherzer, et al.
Journal of Movement Disorders (2023) Vol. 16, Iss. 3, pp. 261-278
Open Access | Times Cited: 13
Extracellular alpha-synuclein: Sensors, receptors, and responses
Renato Domingues, Ricardo Sant’Anna, Anna Carolina Carvalho da Fonseca, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105696-105696
Open Access | Times Cited: 21
Genetic heterogeneity on sleep disorders in Parkinson’s disease: a systematic review and meta-analysis
Jingxuan Huang, Yangfan Cheng, Chunyu Li, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson’s disease
Fahad Mubariz, Afsoon Saadin, Nicholas Lingenfelter, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Curcumin Inhibits α-Synuclein Aggregation by Acting on Liquid–Liquid Phase Transition
Jian-Feng Li, Zi-Qun Jiang, Sen Cao, et al.
Foods (2024) Vol. 13, Iss. 9, pp. 1287-1287
Open Access | Times Cited: 4
Disease-Modifying Therapies in Parkinson’s Disease
Margherita Fabbri, Jean‐Christophe Corvol, Olivier Rascol
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 319-340
Closed Access
Alpha-synuclein expression in anterior pituitary cells of aged cattle
Yvan Bienvenu Niyonzima, Denis Karani Wanjiru, Yuuki Asato, et al.
Domestic Animal Endocrinology (2025) Vol. 92, pp. 106936-106936
Closed Access
Lipid Homeostasis and Its Links With Protein Misfolding Diseases
Michele Vendruscolo
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 17
Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms
Yuliang Han, Zhuohao He
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 9
Tau accumulation in degradative organelles is associated to lysosomal stress
Ester Piovesana, Claudia Magrin, Matteo Ciccaldo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Alessandra Bigi, Roberta Cascella, Cristina Cecchi
Neural Regeneration Research (2023) Vol. 18, Iss. 11, pp. 2332-2342
Open Access | Times Cited: 8
Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms
Norelle C. Wildburger, Anna-Sophia Hartke, Alina Schidlitzki, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top